Singapore markets closed
Straits Times Index
3,265.95 +1.42 (+0.04%) S&P 500
5,187.67 -0.03 (-0.00%) Dow
39,056.39 +172.13 (+0.44%) Nasdaq
16,302.76 -29.80 (-0.18%) Bitcoin USD
60,985.55 -1,445.48 (-2.32%) CMC Crypto 200
1,320.20 +20.11 (+1.55%)
Emergent BioSolutions Inc. (EBS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 231.09M |
| Enterprise value | 1.06B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.20 |
| Price/book (mrq) | 0.35 |
| Enterprise value/revenue | 0.91 |
| Enterprise value/EBITDA | -3.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.24 |
| 52-week change 3 | -58.04% |
| S&P500 52-week change 3 | 25.59% |
| 52-week high 3 | 10.8800 |
| 52-week low 3 | 1.4200 |
| 50-day moving average 3 | 2.5602 |
| 200-day moving average 3 | 2.9723 |
Share statistics
| Avg vol (3-month) 3 | 6.13M |
| Avg vol (10-day) 3 | 19.95M |
| Shares outstanding 5 | 52.4M |
| Implied shares outstanding 6 | 52.4M |
| Float 8 | 51.7M |
| % held by insiders 1 | 1.88% |
| % held by institutions 1 | 78.50% |
| Shares short (15 Apr 2024) 4 | 5.89M |
| Short ratio (15 Apr 2024) 4 | 4.76 |
| Short % of float (15 Apr 2024) 4 | 13.77% |
| Short % of shares outstanding (15 Apr 2024) 4 | 11.25% |
| Shares short (prior month 15 Mar 2024) 4 | 4.91M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -47.69% |
| Operating margin (ttm) | 13.25% |
Management effectiveness
| Return on assets (ttm) | -0.38% |
| Return on equity (ttm) | -60.57% |
Income statement
| Revenue (ttm) | 1.19B |
| Revenue per share (ttm) | 22.93 |
| Quarterly revenue growth (yoy) | 82.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 100.2M |
| Net income avi to common (ttm) | -565.3M |
| Diluted EPS (ttm) | -10.9700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 78.5M |
| Total cash per share (mrq) | 1.5 |
| Total debt (mrq) | 922.2M |
| Total debt/equity (mrq) | 138.91% |
| Current ratio (mrq) | 1.08 |
| Book value per share (mrq) | 12.67 |
Cash flow statement
| Operating cash flow (ttm) | -84.9M |
| Levered free cash flow (ttm) | 133.66M |
© 2024 Yahoo. All rights reserved.